• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter by Koh Regarding Articles, "Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)" and "Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population".

作者信息

Koh Kwang Kon

机构信息

From Department of Cardiovascular Medicine, Heart Center, Gachon University, Gil Medical Center, Incheon, Korea; and Gachon Cardiovascular Research Institute, Incheon, Korea.

出版信息

Circulation. 2017 Mar 28;135(13):e818-e819. doi: 10.1161/CIRCULATIONAHA.116.026360.

DOI:10.1161/CIRCULATIONAHA.116.026360
PMID:28348096
Abstract
摘要

相似文献

1
Letter by Koh Regarding Articles, "Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)" and "Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population".科关于文章《预测中国人群动脉粥样硬化性心血管疾病的10年风险：中国-PAR项目（中国动脉粥样硬化性心血管疾病风险预测）》及《二级预防人群复发性血管事件估计10年风险及残余风险分布》的信函
Circulation. 2017 Mar 28;135(13):e818-e819. doi: 10.1161/CIRCULATIONAHA.116.026360.
2
Response by Yang and Gu to Letter Regarding Article, "Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)".
Circulation. 2017 Mar 28;135(13):e822-e823. doi: 10.1161/CIRCULATIONAHA.117.027318.
3
Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China).预测中国人群动脉粥样硬化性心血管疾病 10 年风险：中国 PAR 项目（中国 ASCVD 风险预测）。
Circulation. 2016 Nov 8;134(19):1430-1440. doi: 10.1161/CIRCULATIONAHA.116.022367. Epub 2016 Sep 28.
4
[Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].[接受降脂治疗的血脂异常患者动脉粥样硬化性心血管疾病一级和二级预防中胆固醇目标达成情况：中国血脂异常防治研究（DYSIS-China）亚组分析]
Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Aug 24;44(8):665-70. doi: 10.3760/cma.j.issn.0253-3758.2016.08.006.
5
Prediction of 10-year Atherosclerotic Cardiovascular Disease Risk among Adults Aged 40-79 Years in China: a Nationally Representative Survey.中国40-79岁成年人10年动脉粥样硬化性心血管疾病风险预测：一项全国代表性调查。
Biomed Environ Sci. 2017 Apr;30(4):244-254. doi: 10.3967/bes2017.034.
6
Risk stratification of atherosclerotic cardiovascular disease in Chinese adults.中国成年人动脉粥样硬化性心血管疾病的风险分层
Chronic Dis Transl Med. 2016 Oct 21;2(2):102-109. doi: 10.1016/j.cdtm.2016.10.001. eCollection 2016 Jun.
7
Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study.中国北方农村人群动脉粥样硬化性心血管病风险预测模型的表现：来自房山队列研究的结果。
Am Heart J. 2019 May;211:34-44. doi: 10.1016/j.ahj.2019.01.009. Epub 2019 Feb 5.
8
Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project.饮茶与动脉粥样硬化性心血管疾病及全因死亡率的关系：中国前瞻性研究项目。
Eur J Prev Cardiol. 2020 Dec;27(18):1956-1963. doi: 10.1177/2047487319894685. Epub 2020 Jan 8.
9
[Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].[中国北方农村人群心血管疾病一级预防中不同筛查策略的有效性]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Jun 18;50(3):443-449.
10
[Aspirin use in patients with atherosclerotic cardiovascular disease: the 2016 Chinese expert consensus statement].《阿司匹林在动脉粥样硬化性心血管疾病患者中的应用：2016中国专家共识声明》
Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):68-80. doi: 10.3760/cma.j.issn.0578-1426.2017.01.020.